The leukemic BM microenvironment of MDS and AML further dysregulates the anti-tumor response of CD8+ T cells through the expansion and aberrant functionality of Tregs and MDSCs [17,18,92,100]. The gene discussed is CD8A; the disease is myelodysplastic syndrome.